BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,000 | +16.7% | 11,026 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -36.8% | 11,026 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | -9.5% | 11,026 | +74.3% | 0.00% | – |
| Q1 2019 | $21,000 | -22.2% | 6,326 | -30.7% | 0.00% | – |
| Q4 2018 | $27,000 | -70.7% | 9,132 | -39.0% | 0.00% | -100.0% |
| Q3 2018 | $92,000 | -51.1% | 14,969 | -41.2% | 0.00% | -50.0% |
| Q2 2018 | $188,000 | +1466.7% | 25,475 | +1309.8% | 0.00% | – |
| Q1 2018 | $12,000 | -45.5% | 1,807 | -31.7% | 0.00% | – |
| Q4 2017 | $22,000 | -89.8% | 2,644 | -85.8% | 0.00% | -100.0% |
| Q3 2017 | $215,000 | +497.2% | 18,574 | +502.5% | 0.00% | – |
| Q2 2017 | $36,000 | +227.3% | 3,083 | +285.4% | 0.00% | – |
| Q4 2016 | $11,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |